Clinical biology of the pituitary adenoma

S Melmed, UB Kaiser, MB Lopes, J Bertherat… - Endocrine …, 2022 - academic.oup.com
All endocrine glands are susceptible to neoplastic growth, yet the health consequences of
these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent …

Diagnosis and management of precocious sexual maturation: an updated review

AV Cheuiche, LG da Silveira, LCP de Paula… - European journal of …, 2021 - Springer
The classic definition of precocious sexual maturation is the development of secondary
sexual characteristics before 8 years of age in girls and before 9 years of age in boys. It is …

[PDF][PDF] Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation

AM Boyce, MT Collins - Endocrine reviews, 2020 - academic.oup.com
Abstract Fibrous dysplasia/McCune-Albright syndrome (FD/MAS) is a rare disorder of
striking complexity. It arises from somatic, gain-of-function mutations in GNAS, leading to …

Gαs–Protein kinase a (PKA) pathway signalopathies: the emerging genetic landscape and therapeutic potential of human diseases driven by aberrant Gαs-PKA …

DJ Ramms, F Raimondi, N Arang, FW Herberg… - Pharmacological …, 2021 - ASPET
Many of the fundamental concepts of signal transduction and kinase activity are attributed to
the discovery and crystallization of cAMP-dependent protein kinase, or protein kinase A …

The clinical spectrum of McCune-Albright syndrome and its management

T Spencer, KS Pan, MT Collins… - Hormone research in …, 2020 - karger.com
McCune-Albright syndrome (MAS) is a rare, mosaic disorder presenting along a broad
clinical spectrum. Disease arises from somatic-activating GNAS mutations, leading to …

Increased uptake of 68Ga-DOTA-FAPI-04 in bones and joints: metastases and beyond

C Qin, Y Song, X Liu, Y Gai, Q Liu, W Ruan… - European journal of …, 2022 - Springer
Purpose To describe the uptake of 68 Gallium-labelled fibroblast activation protein inhibitor
(68 Ga-FAPI) in the bones and joints for better understanding of the role of 68 Ga-FAPI PET …

[HTML][HTML] A rare skeletal disorder, fibrous dysplasia: a review of its pathogenesis and therapeutic prospects

HY Kim, JH Shim, CY Heo - International Journal of Molecular Sciences, 2023 - mdpi.com
Fibrous dysplasia (FD) is a rare, non-hereditary skeletal disorder characterized by its chronic
course of non-neoplastic fibrous tissue buildup in place of healthy bone. A myriad of factors …

[HTML][HTML] Current concepts of craniofacial fibrous dysplasia: pathophysiology and treatment

DY Kim - Archives of Craniofacial Surgery, 2023 - ncbi.nlm.nih.gov
Fibrous dysplasia is an uncommon genetic disorder in which bone is replaced by immature
bone and fibrous tissue, manifesting as slow-growing lesions. Sporadic post-zygotic …

Pain phenotypes in rare musculoskeletal and neuromuscular diseases

A Tucker-Bartley, J Lemme, A Gomez-Morad… - Neuroscience & …, 2021 - Elsevier
For patients diagnosed with a rare musculoskeletal or neuromuscular disease, pain may
transition from acute to chronic; the latter yielding additional challenges for both patients and …

Bisphosphonates for the treatment of fibrous dysplasia of bone

R Chapurlat, MA Legrand - Bone, 2021 - Elsevier
Introduction Fibrous dysplasia of bone (FD) is a rare congenital bone disease, due to a
somatic mutation of GNAS. This mutation results in a defect of osteoblast differentiation and …